SSD114 hydrochloride is primarily utilized in the field of medical research, particularly in the study of neurological disorders. It serves as a potent and selective inhibitor of certain enzymes that are implicated in the pathology of diseases such as Alzheimer's and Parkinson's. By inhibiting these enzymes, SSD114 hydrochloride helps researchers understand the biochemical pathways involved in neurodegeneration, paving the way for the development of targeted therapeutic strategies. Additionally, it is used in preclinical studies to evaluate the efficacy and safety of new drugs aimed at treating cognitive impairments and other related conditions. Its role in these studies is crucial for advancing our understanding of complex brain functions and disorders.